PROTAC degraders as chemical probes for studying target biology and target validation DOI
Václav Nêmec, Martin P. Schwalm, Susanne Müller

и другие.

Chemical Society Reviews, Год журнала: 2022, Номер 51(18), С. 7971 - 7993

Опубликована: Янв. 1, 2022

This review provides guidelines for the optimization of proteolysis targeting chimeras (PROTACs) and outlines criteria their use as chemical probes.

Язык: Английский

Kinase inhibitors: the road ahead DOI
Fleur M. Ferguson, Nathanael S. Gray

Nature Reviews Drug Discovery, Год журнала: 2018, Номер 17(5), С. 353 - 377

Опубликована: Март 16, 2018

Язык: Английский

Процитировано

895

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology DOI
Matthias Gehringer, Stefan Laufer

Journal of Medicinal Chemistry, Год журнала: 2018, Номер 62(12), С. 5673 - 5724

Опубликована: Дек. 19, 2018

Targeted covalent inhibitors (TCIs) are designed to bind poorly conserved amino acids by means of reactive groups, the so-called warheads. Currently, targeting noncatalytic cysteine residues with acrylamides and other α,β-unsaturated carbonyl compounds is predominant strategy in TCI development. The recent ascent drugs has stimulated considerable efforts characterize alternative warheads for covalent-reversible irreversible engagement as well acids. This Perspective article provides an overview warheads-beyond amides-recently used design targeted ligands. Promising groups that have not yet demonstrated their utility development also highlighted. Special emphasis placed on discussion reactivity case studies illustrating applications medicinal chemistry chemical biology.

Язык: Английский

Процитировано

584

Trends in kinase drug discovery: targets, indications and inhibitor design DOI
Misty M. Attwood, Doriano Fabbro, Aleksandr V. Sokolov

и другие.

Nature Reviews Drug Discovery, Год журнала: 2021, Номер 20(11), С. 839 - 861

Опубликована: Авг. 5, 2021

Язык: Английский

Процитировано

582

Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening DOI Creative Commons
Efrat Resnick, A.R. Bradley,

Jinrui Gan

и другие.

Journal of the American Chemical Society, Год журнала: 2019, Номер 141(22), С. 8951 - 8968

Опубликована: Май 7, 2019

Covalent probes can display unmatched potency, selectivity, and duration of action; however, their discovery is challenging. In principle, fragments that irreversibly bind target overcome the low affinity limits reversible fragment screening, but such electrophilic were considered nonselective rarely screened. We hypothesized mild electrophiles might selectivity challenge constructed a library 993 mildly fragments. characterized this by new high-throughput thiol-reactivity assay screened them against 10 cysteine-containing proteins. Highly reactive promiscuous rare could be easily eliminated. contrast, we found hits for most targets. Combining our approach with crystallography allowed rapid progression to potent selective two enzymes, deubiquitinase OTUB2 pyrophosphatase NUDT7. No inhibitors previously known either. This study highlights potential electrophile-fragment screening as practical efficient tool covalent-ligand discovery.

Язык: Английский

Процитировано

280

Advances in covalent kinase inhibitors DOI

Ayah Abdeldayem,

Yasir S. Raouf, Stefan N. Constantinescu

и другие.

Chemical Society Reviews, Год журнала: 2020, Номер 49(9), С. 2617 - 2687

Опубликована: Янв. 1, 2020

Over the past decade, covalent kinase inhibitors (CKI) have seen a resurgence in drug discovery. Covalency affords unique set of advantages as well challenges relative to their non-covalent counterpart. After reversible protein target recognition and binding, irreversibly modify proximal nucleophilic residue on via reaction with an electrophile. To date, acrylamide group remains predominantly employed electrophile CKI development, its incorporation majority clinical candidates FDA approved therapies. Nonetheless, recent years considerable efforts ensued characterize alternative electrophiles that exhibit irreversible or reversibly binding mechanisms towards cysteine thiols other amino acids. This review article provides comprehensive overview CKIs reported literature over decade period, 2007-2018. Emphasis is placed rationale behind warhead choice, optimization approach, inhibitor design. Current are also highlighted, addition detailed analysis common trends themes observed within listed data set.

Язык: Английский

Процитировано

257

A proteome-wide atlas of lysine-reactive chemistry DOI Open Access

Mikail E. Abbasov,

Madeline E. Kavanagh, Taka-Aki Ichu

и другие.

Nature Chemistry, Год журнала: 2021, Номер 13(11), С. 1081 - 1092

Опубликована: Сен. 9, 2021

Язык: Английский

Процитировано

182

Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation DOI Creative Commons
Tinghu Zhang, John M. Hatcher, Mingxing Teng

и другие.

Cell chemical biology, Год журнала: 2019, Номер 26(11), С. 1486 - 1500

Опубликована: Окт. 17, 2019

Язык: Английский

Процитировано

148

Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors DOI Creative Commons
Christopher Arter,

Luke Trask,

Sarah Ward

и другие.

Journal of Biological Chemistry, Год журнала: 2022, Номер 298(8), С. 102247 - 102247

Опубликована: Июль 10, 2022

Protein kinases are key components in cellular signaling pathways as they carry out the phosphorylation of proteins, primarily on Ser, Thr, and Tyr residues. The catalytic activity protein is regulated, can be thought molecular switches that controlled through protein-protein interactions post-translational modifications. exhibit diverse structural mechanisms regulation have been fascinating subjects for biologists from first crystal structure a kinase over 30 years ago, to recent insights into assemblies enabled by breakthroughs cryo-EM. high-priority targets drug discovery oncology other disease settings, inhibitors transformed outcomes specific groups patients. Most ATP competitive, deriving potency occupying deep hydrophobic pocket at heart domain. Selectivity depends exploiting differences between amino acids line site exploring surrounding pockets present inactive states kinase. More recently, allosteric outside being targeted achieve high selectivity overcome resistance current therapeutics. Here, we review regulatory features family, describe different types inhibitors, highlight examples where understanding has gone hand with development inhibitors.

Язык: Английский

Процитировано

104

Reversible lysine-targeted probes reveal residence time-based kinase selectivity DOI
Tangpo Yang, Adolfo Cuesta, Xiaobo Wan

и другие.

Nature Chemical Biology, Год журнала: 2022, Номер 18(9), С. 934 - 941

Опубликована: Май 19, 2022

Язык: Английский

Процитировано

76

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update DOI

Laura Hillebrand,

Xiaojun Julia Liang,

Ricardo A. M. Serafim

и другие.

Journal of Medicinal Chemistry, Год журнала: 2024, Номер 67(10), С. 7668 - 7758

Опубликована: Май 7, 2024

Covalent inhibitors and other types of covalent modalities have seen a revival in the past two decades, with variety new targeted drugs having been approved recent years. A key feature such molecules is an intrinsically reactive group, typically weak electrophile, which enables irreversible or reversible formation bond specific amino acid target protein. This often called "warhead", critical determinant ligand's activity, selectivity, general biological properties. In 2019, we summarized emerging re-emerging warhead chemistries to cysteine acids (Gehringer, M.; Laufer, S. A. J. Med. Chem. 62, 5673−5724; DOI: 10.1021/acs.jmedchem.8b01153). Since then, field has rapidly evolved. Here discuss progress on warheads made since our last Perspective their application medicinal chemistry chemical biology.

Язык: Английский

Процитировано

53